164 related articles for article (PubMed ID: 29039496)
1. GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
Liu K; Li J; Wu X; Chen M; Luo F; Li J
Int J Oncol; 2017 Dec; 51(6):1821-1830. PubMed ID: 29039496
[TBL] [Abstract][Full Text] [Related]
2. Effects of the GSK-3β inhibitor (2Z,3E)-6-bromoindirubin-3'-oxime upon ovarian cancer cells.
Yu AS; Zhao L
Tumour Biol; 2016 Apr; 37(4):4857-64. PubMed ID: 26526575
[TBL] [Abstract][Full Text] [Related]
3. Stabilizing and upregulating Axin with tankyrase inhibitor reverses 5-fluorouracil chemoresistance and proliferation by targeting the WNT/caveolin-1 axis in colorectal cancer cells.
Luo F; Li J; Liu J; Liu K
Cancer Gene Ther; 2022 Nov; 29(11):1707-1719. PubMed ID: 35750753
[TBL] [Abstract][Full Text] [Related]
4. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance.
Luo F; Li J; Wu S; Wu X; Chen M; Zhong X; Liu K
Oncotarget; 2016 Sep; 7(39):63937-63949. PubMed ID: 27613840
[TBL] [Abstract][Full Text] [Related]
5. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
[TBL] [Abstract][Full Text] [Related]
6. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β.
Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY
Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646
[TBL] [Abstract][Full Text] [Related]
7. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556
[TBL] [Abstract][Full Text] [Related]
8. GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression.
Ko KH; Holmes T; Palladinetti P; Song E; Nordon R; O'Brien TA; Dolnikov A
Stem Cells; 2011 Jan; 29(1):108-18. PubMed ID: 20960517
[TBL] [Abstract][Full Text] [Related]
9. B-cell translocation gene 3 overexpression inhibits proliferation and invasion of colorectal cancer SW480 cells via Wnt/β-catenin signaling pathway.
Mao D; Qiao L; Lu H; Feng Y
Neoplasma; 2016; 63(5):705-16. PubMed ID: 27468874
[TBL] [Abstract][Full Text] [Related]
10. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
11. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
12. ADAMDEC1 induces EMT and promotes colorectal cancer cells metastasis by enhancing Wnt/β-catenin signaling via negative modulation of GSK-3β.
Jia Y; Huang X; Shi H; Wang M; Chen J; Zhang H; Hou D; Jing H; Du J; Han H; Zhang J
Exp Cell Res; 2023 Aug; 429(2):113629. PubMed ID: 37187249
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
[TBL] [Abstract][Full Text] [Related]
14. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
[TBL] [Abstract][Full Text] [Related]
16. Toosendanin inhibits growth and induces apoptosis in colorectal cancer cells through suppression of AKT/GSK-3β/β-catenin pathway.
Wang G; Feng CC; Chu SJ; Zhang R; Lu YM; Zhu JS; Zhang J
Int J Oncol; 2015 Nov; 47(5):1767-74. PubMed ID: 26398368
[TBL] [Abstract][Full Text] [Related]
17. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
[TBL] [Abstract][Full Text] [Related]
18. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
20. 6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.
Xingi E; Smirlis D; Myrianthopoulos V; Magiatis P; Grant KM; Meijer L; Mikros E; Skaltsounis AL; Soteriadou K
Int J Parasitol; 2009 Oct; 39(12):1289-303. PubMed ID: 19445946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
